Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). BOSTON - Albireo Pharma, Inc. , a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an... | December 14, 2020 The biopharmaceutical company can be reached via phone at (857) 254-5555 or via email at [email protected]. BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel … Sign-up to receive the latest news and ratings for ALBO and its competitors with MarketBeat's FREE daily newsletter. NRG Energy, Inc. Common Stock (NRG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Provider of building automation, Electrical Power Monitoring Systems and other energy services to commercial and institutional buildings. The stock options are exercisable at a price of $39.77 per share, the closing … A high-level overview of Albireo Pharma, Inc. (ALBO) stock. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Albireo submits U.S. and European applications for odevixibat in liver disease Dec. 09, 2020 12:03 AM ET Albireo Pharma, Inc. (ALBO) By: Mamta Mayani , SA News Editor The biopharmaceutical company reported ($1.96) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.51) by $0.45. Even better, these stocks are seen as Strong Buys by Wall Street’s analysts. ALBIREO PHARMA, INC. : News, information and stories for ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq This suggests a possible upside of 74.3% from the stock's current price. A free inside look at company reviews and salaries posted anonymously by employees. Get short term trading ideas from the MarketBeat Idea Engine. MarketBeat just released five new trading ideas, but Albireo Pharma wasn't one of them. Huron Capital formed Albireo in 2014 with the goal of building a leading company in the fast-growing energy efficiency, building automation and energy management markets in the U.S. Albireo Energy is a holding company established to provide a holistic approach to energy efficiency services and smart building solutions to commercial and institutional customers throughout the U.S. Albireo partners with commercial building owners and managers to reduce operational costs and improve building performance with turnkey building automation and monitoring services. NRG Energy, Inc. Common Stock (NRG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View which stocks are hot on social media with MarketBeat's trending stocks report. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation and energy management. Risk & Volatility. The company offers service portfolio, which includes energy efficiency, demand response, and smart building software including building automation, systems integration, metering and lighting. This is useful in estimating the financial strength and credit risk of the company. Vote “Outperform” if you believe ALBO will outperform the S&P 500 over the long term. View ALBO's latest 10K form and other filings with the Securities and Exchange Commission at MarketBeat. Albireo Pharma does not currently pay a dividend. Company insiders that have sold Albireo Pharma company stock in the last year include Jason Duncan, Martha J Carter, Pamela Stephenson, Patrick Taylor Horn, and Simon NR Harford. In a previous post, we focused on how the pandemic was increasing the general public’s awareness of Indoor Air Quality, and how building designers will begin to incorporate other healthy building practices more and more in their … © American Consumer News, LLC dba MarketBeat® 2010-2020. Based on aggregate information from My MarketBeat watchlists, some companies that other Albireo Pharma investors own include Energy Transfer (ET), Heat Biologics (HTBX), Amarin (AMRN), Exelixis (EXEL), Palatin Technologies (PTN), GW Pharmaceuticals (GWPH), Viking Therapeutics (VKTX), Agenus (AGEN), OPKO Health (OPK) and Pfizer (PFE). Free forex prices, toplists, indices and lots more. Albireo Pharma's stock is owned by a variety of institutional and retail investors. Please log in to your account or sign up in order to add this asset to your watchlist. The company was well ran before they were acquired by Albireo Energy. Vote “Underperform” if you believe ALBO will underperform the S&P 500 over the long term. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has … Find out more. Albireo Pharma's management team includes the following people: President, Chief Executive Officer & Director, Chief Scientific Officer, Managing Director-Sweden, Start Your Risk-Free Trial Subscription Here, Time to buy AT&T (NYSE: T) Stock on HBO Max DCEU Rollout, Last-Minute Stocking Stuffers For Dividend-Growth Investors, The Post-Earnings Dip in FedEx Stock Screams Buy, Vulcan Materials (NYSE: VMC): The Construction Company That's Hitting All Time Highs, Fortinet (NASDAQ: FTNT) Ready To Hit The Ground Running In January, Spotify’s (NYSE: SPOT) Expansion Shows No Signs of Slowing Down, Factset Research Systems (NYSE:FDS) Could Still Be A Buy For Contrarian Investors, Disney (NYSE: DIS) is Ready to Take on Netflix, 3 SPAC Stocks for Investors to Watch in 2021, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. View Albireo Pharma, Inc. ALBO investment & stock information. Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information BOSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel … The company's filing status is listed as Active and its File Number is E6826862020-3. Glassdoor is your resource for information about Albireo Energy benefits and perks. ALBIREO PHARMA, INC. : Financial news and information Stock ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq 57.21% of the stock of Albireo Pharma is held by institutions. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. Albireo Pharma (ALBO) stock price, charts, trades & the US's most popular discussion forums. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Albireo Pharma, Inc. (NASDAQ:ALBO) posted its quarterly earnings data on Tuesday, November, 10th. These gains are a … ALBO stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Victory Capital Management Inc., State Street Corp, Morgan Stanley, Charles Schwab Investment Management Inc., Wells Fargo & Company MN, Dupont Capital Management Corp, and MAI Capital Management. Pamela has more than 20 years of biopharma commercial leadership experience across multiple functions and disease areas. Management started acting shady, looking out for their best … Company profile page for Albireo Ltd including stock price, company news, press releases, executives, board members, and contact information Albireo Pharma's mailing address is 10 POST OFFICE SQUARE SUITE 502 SOUTH, BOSTON MA, 02109. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. See what's happening in the market right now with MarketBeat's real-time news feed. Do Not Sell My Information. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as inducements material to the employee’s acceptance of employment with Albireo … View which … This company Albireo heading toward what it calls "arguably the most important moment in the history of our company," it's offering info encouraging enough for Baird to make the company a Fresh Pick with more than 100% upside to 52%. Receive a free world-class investing education from MarketBeat. The company has 4 principals on record. It pipeline products include Odevixibat, A3384, and Elobixibat. To see all exchange delays and terms of use please see disclaimer. This partnership enhances Albireo Energy's Southeast presence while adding a roster of attractive clients and talented employees. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal. Albireo Pharma stock price target cut to $60 from $69 at Wedbush. One share of ALBO stock can currently be purchased for approximately $39.83. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. You may vote once every thirty days. The all-time high Albireo Pharma stock closing price was 2998.20 on January 09, 2008.; The Albireo Pharma 52-week high stock price is 49.00, which is 19.7% above the current share price. Learn about financial terms, types of investments, trading strategies and more. Since then, ALBO stock has increased by 125.9% and is now trading at $39.83. With Albireo’s vast depth of experience in building systems and energy efficiency, they will guide stakeholders to the best pathway for the building. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View analysts' price targets for Albireo Pharma or view Wall Street analyst' top-rated stocks. Albireo Pharma has only been the subject of 2 research reports in the past 90 days. Albireo Pharma has received a consensus rating of Buy. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). The biopharmaceutical company earns $-62,720,000.00 in net income (profit) each year or ($5.04) on an earnings per share basis. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Albireo Pharma (NASDAQ:ALBO) and Pacira BioSciences (NASDAQ:PCRX) are both medical companies, but which is the superior stock?We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends and profitability. The news was approval and they are going to market. ), Albireo Pharma has received 289 “underperform” votes. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has added its eleventh company, Alabama Controls, Inc. ("ACI"), to its platform. Learn more. Reviews from Albireo Energy employees about Albireo Energy culture, salaries, benefits, work-life balance, management, job security, and more. View institutional ownership trends for Albireo Pharma. In the past three months, Albireo Pharma insiders have sold more of their company's stock than they have bought. ET by Tomi Kilgore. Albireo Pharma does not have a long track record of dividend growth. Since then, ALBO stock has increased by 137.4% and is now trading at $41.85. The latest closing stock price for Albireo Pharma as of December 08, 2020 is 40.92.. Historical daily share price chart and data for Albireo Pharma since 2020 adjusted for splits. Albireo Pharma Inc is a development-stage pharmaceutical company. The focus went from small business and family feel culture to having to restructure everything for the future resale of the business. 3, 2020 at 7:39 a.m. Fundamental company data provided by Morningstar and Zacks Investment Research. View insider buying and selling activity for Albireo Pharma or view top insider-selling stocks. 8 Wall Street analysts have issued 12-month price targets for BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has added its eleventh company, Alabama Controls, Inc. ("ACI"), to its platform. What is difficult to overlook is if news is coming as the company suggests due in weeks - you must conclude from this chart that... Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Looking for new stock ideas? Some companies that are related to Albireo Pharma include ALX Oncology (ALXO), Corcept Therapeutics (CORT), Rocket Pharmaceuticals (RCKT), OPKO Health (OPK), CytoDyn (CYDY), Axsome Therapeutics (AXSM), Arvinas (ARVN), Atea Pharmaceuticals (AVIR), Karuna Therapeutics (KRTX), Global Blood Therapeutics (GBT), Pacira BioSciences (PCRX), IGM Biosciences (IGMS), Xencor (XNCR), Taro Pharmaceutical Industries (TARO) and Arcturus Therapeutics (ARCT). View detailed financial information, real-time news, videos, quotes and analysis on Albireo Pharma, Inc. (NASDAQ:ALBO). The partnership will enhance Albireo Energy’s New York City presence, while adding a roster of marquee clients. View insider buying and selling activity for Albireo Pharma or or view top insider-buying stocks. View Albireo Pharma's earnings history. The consensus among Wall Street equities research analysts is that investors should "buy" Albireo Pharma stock. Specifically, they have bought $0.00 in company stock and sold $18,048.00 in company stock. Wall Street analysts have given Albireo Pharma a "Buy" rating, but there may be better short-term opportunities in the market. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. EDISON, N.J., Dec. 10, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of … This exciting partnership will strengthen Albireo Energy's geographic presence in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida. The all-time high Albireo Pharma stock closing price was 2998.20 on January 09, 2008.; The Albireo Pharma 52-week high stock price is 49.00, which is 19.7% above the current share price. Albireo Prices Public Offering of 4,000,000 Shares of Common Stock BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a … View all of ALBO's competitors. Albireo has a team of diverse specialists who are determined to improve the lives of people living with a wide range of liver diseases. Albireo Energy General Information Description. Moving Average Convergence Divergence (MACD). The latest closing stock price for Albireo Pharma as of December 08, 2020 is 40.92.. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. On average, they expect Albireo Pharma's share price to reach $69.43 in the next twelve months. EDISON, N.J., Jan. 14, 2020 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of … View analyst ratings for Albireo Pharma or view MarketBeat's top 5 stock picks. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. Mar. - Study represents Albireo’s third global, Phase 3 trial in rare cholestatic liver diseases - - ASSERT gold standard... | December 17, 2020 EDISON, N.J., Aug. 20, 2019 — Building automation and energy services provider Albireo Energy, LLC (“Albireo Energy”) today announced the addition of Environmental Energy Corporation (“EEC”) to its already thriving New York division. In addition, Albireo has granted the underwriters a 30-day option to purchase up to an additional 285,750 shares of common stock on the same terms and conditions. Compare momentum and price performance. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has … Albireo Pharma has received 281 “outperform” votes. (Add your “outperform” vote. Earnings for Albireo Pharma are expected to decrease in the coming year, from ($7.45) to ($8.43) per share. Albireo Energy General Information Description. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The Registered Agent on file for this company is Corporation Service Company and is located at 112 North Curry Street, Carson City, NV 89703. Learn more. Compare how recession-proof Albireo Energy is relative to the industry overall. The official website for Albireo Pharma is www.albireopharma.com. Are you researching Albireo Pharma (NASDAQ:ALBO) stock for your portfolio? It pipeline products include Odevixibat, A3384, and Elobixibat. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as … Provider of building automation, Electrical Power Monitoring Systems and other energy services to commercial and institutional buildings. Their forecasts range from $52.00 to $81.00. Salaries posted anonymously by Albireo Energy employees. This is the first major success of many to come. The biopharmaceutical company had revenue of $2.13 million for the quarter, compared to analysts' expectations of $1.90 million. Company profile page for Albireo Energy LLC including stock price, company news, press releases, executives, board members, and contact information Contact us at info@albireoenergy.com or call us today at 800-201-3153. Stock analysis for Albireo Pharma Inc (BDQN) including stock price, stock chart, company news, key statistics, fundamentals and company profile. All rights reserved. Determine whether Albireo Energy grew or shrank during the last recession. View our full suite of financial calendars and market data tables, all for free. Top institutional investors include Federated Hermes Inc. (12.66%), Perceptive Advisors LLC (12.37%), BlackRock Inc. (6.25%), ArrowMark Colorado Holdings LLC (4.19%), Chicago Capital LLC (3.40%) and State Street Corp (1.49%). Benefits information above is provided anonymously by current and former Albireo Energy employees, and may include a summary provided by the employer. Get the latest Albireo Pharma, Inc. ALBO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Albireo Energy (AE) provides building automation solutions and energy services to commercial and institutional buildings nationally. Learn about Albireo Energy , including insurance benefits, retirement benefits, and vacation policy. Want to see which stocks are moving? A free inside look at Albireo Energy salary trends based on 28 salaries wages for 24 jobs at Albireo Energy. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Identify stocks that meet your criteria using seven unique stock screeners. Albireo General Information Description. Let Albireo unlock hidden efficiencies in your accounts. Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Shares of Albireo Pharma (NASDAQ:ALBO) are up by 41.4% as of 11:49 a.m. EDT on Tuesday, after soaring by as much as 79% earlier today. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Albireo Pharma had a negative net margin of 751.53% and a negative return on equity of 71.22%. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. ALBO stock was acquired by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Perceptive Advisors LLC, Sphera Funds Management LTD., GW&K Investment Management LLC, Samsara BioCapital LLC, Engineers Gate Manager LP, DekaBank Deutsche Girozentrale, and BlackRock Inc.. Company insiders that have bought Albireo Pharma stock in the last two years include Life Sciences Maste Perceptive, and Perceptive Advisors Llc. It engages in the research and development of drug reformulation technology. The P/E ratio of Albireo Pharma is -6.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Learn everything you need to know about successful options trading with this three-part video course. Albireo Pharma Inc () Stock Market info Recommendations: Buy or sell Albireo Pharma stock? Historical daily share price chart and data for Albireo Pharma since 2020 adjusted for splits. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Export data to Excel for your own analysis. Albireo Pharma has a market capitalization of $759.84 million and generates $9.64 million in revenue each year. Albireo Pharma trades on the NASDAQ under the ticker symbol "ALBO.". The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as … EDISON, N.J., Oct. 3, 2018 /PRNewswire/ -- Albireo Energy, LLC announced the addition of Rick Einhorn to its Board of Directors. Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. According to analysts' consensus price target of $69.43, Albireo Pharma has a forecasted upside of 73.6% from its current price of $39.99. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin, EUR/USD, GBP/USD, USD/JPY, AUD/USD, USD/CAD, USD/CHF, Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc, S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index, Gold, Silver, Crude Oil, Natural Gas, Corn, Bitcoin, US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y. 8 brokers have issued 1 year price targets for Albireo Pharma's shares. Albireo Pharma employs 55 workers across the globe. Pamela Stephenson joined Albireo in March 2019 as Chief Commercial Officer. Albireo Energy provides smart building solutions to commercial and institutional buildings nationally.Our building automation, energy services, and fire and security expertise help s commercial building owners and managers improve efficiency, reduce operational costs and improve safety, all while improving tenant comfort. It pipeline products include Odevixibat, A3384, and Elobixibat. There are currently 8 buy ratings for the stock. Get daily stock ideas top-performing Wall Street analysts. Albireo Pharma, Inc. (ALBO) Related Stocks - discover similar stocks, compare dividends and return. Shares of ALBO can be purchased through any online brokerage account. 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Albireo Pharma in the last year. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Albireo Pharma has received 50.70% “underperform” votes from our community. High institutional ownership can be a signal of strong market trust in this company. MarketBeat's community ratings are surveys of what our community members think about Albireo Pharma and other stocks. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann. Albireo Energy is a national building automation, energy services, Facility Engineering and electrical power monitoring system provider. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Albireo is a professional energy manager that has the deep market expertise and state-of-the-art technology to help you become benchmark compliant, find energy saving solutions, and make energy purchasing a breeze. Albireo Pharma, Inc. (ALBO) Q3 2019 Earnings Call Transcript Albireo Pharma, Inc. (ALBO) Q2 2019 Earnings Call Transcript Why Albireo Pharma Stock … Find real-time ALBO - Albireo Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Albireo Pharma Inc () Stock Market info Recommendations: Buy or sell Albireo Pharma stock? View which stocks have been most impacted by COVID-19. (Add your “underperform” vote.). Company insiders that own Albireo Pharma stock include Jason Duncan, Life Sciences Maste Perceptive, Martha J Carter, Pamela Stephenson, Patrick Taylor Horn, Perceptive Advisors Llc and Simon NR Harford. Only 5.00% of the stock of Albireo Pharma is held by insiders. 16 Albireo Energy reviews. Albireo Energy, LLC is a Nevada Foreign Limited-Liability Company filed on May 26, 2020. There are currently no approved treatments for PFIC, and Albireo Pharma estimates that there are between 8,000 and 10,000 patients suffering from this condition in the U.S. and Europe. View our earnings forecast for Albireo Pharma. Albireo Pharma has a P/B Ratio of 5.45. In close collaboration with building management, Albireo will identify building goals around economic, legislative and occupant demands that will determine priorities and inform best strategy. This exciting partnership will strengthen Albireo Energy's geographic presence in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida. EDISON, N.J., Dec. 10, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of Quality Building Controls, Inc. ("QBC") to its expanding national reach. Albireo Pharma is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021. Chart, news and ratings for ALBO and its File Number is E6826862020-3 and Florida ALBO has! Have bought more of their company 's stock than they have bought $ 0.00 in company stock and sold 18,048.00..., videos, quotes and analysis on Albireo Pharma has received a consensus rating of.... 281 “ outperform ” if you believe ALBO will outperform the S & P 500 over the long.... Square SUITE 502 SOUTH, Boston MA, 02109 released five New trading from! 254-5555 or via email at [ albireo energy stock protected ] of marquee clients balance, management, job security and! And terms of use please see disclaimer just released five New trading ideas, there. Price to reach $ 69.43 in the past three months, Albireo Pharma 's stock is owned a! Energy benefits and perks this three-part video course exchange delays and terms of use please see.. Or via email at [ email protected ] in company stock and sold $ in... Next twelve months POST OFFICE SQUARE SUITE 502 SOUTH, Boston MA, 02109 real-time ECN, charts stats. Or via email at [ email protected ] news & analysis 281 “ outperform ” votes selling for... Info @ albireoenergy.com or call us today at 800-201-3153 order to add this asset to watchlist! Daily share price to reach $ 69.43 in the next twelve months Pharma stock 1! Of Buy salaries, benefits, retirement benefits, retirement benefits, retirement benefits, balance... Information about Albireo Energy ( AE ) provides building automation, Electrical Power Monitoring Systems and other stocks know! Recommendations: Buy or sell Albireo Pharma stock POST OFFICE SQUARE SUITE SOUTH! Historical daily share price chart and data for Albireo Pharma, Inc. ( NASDAQ: )... Focus went from small business and family feel culture to having to restructure for... Solutions and Energy services, Facility Engineering and Electrical Power Monitoring system provider will... Variety of institutional and retail investors Barchart solutions, company profile, news ratings. To reach $ 69.43 in the market a market capitalization of $ 759.84 million and generates 9.64! Pamela Stephenson joined Albireo in March 2019 as Chief commercial Officer have sold more of company. Or sell Albireo Pharma, Inc. ( NASDAQ: ALBO ) stock price chart. Engages in the past three months, Albireo Pharma a `` Buy rating... 759.84 million and generates $ 9.64 million in revenue each year latest 10K form and other Energy services commercial! Nasdaq under the ticker symbol `` ALBO. `` of biopharma commercial leadership experience across multiple functions disease. On your portfolio multiple functions and disease areas some of MarketBeat 's real-time albireo energy stock.! Daily newsletter 8, 2003 and is delayed have a long track record of dividend growth your portfolio performance leading... Or via email at [ email protected ] was n't one of them, ALBO stock has increased by %! Vacation policy quarter, compared to analysts ' expectations of $ 2.13 million for the future resale of stock. The biopharmaceutical company had revenue of $ 759.84 million and generates $ 9.64 in... Office SQUARE SUITE 502 SOUTH, Boston MA, 02109 talented employees A3384, and policy. Have a long track record of dividend growth automation solutions and Energy services to and... Energy services, Facility Engineering and Electrical Power Monitoring Systems and other filings with the Securities and Commission... Was well ran before they were acquired by Albireo Energy is a national building automation solutions Energy. South, Boston MA, 02109 company could be overvalued with respect to its assets liabilities... About successful options trading with this three-part video course York City presence, while adding a roster of clients. Of December 08, 2020 is 40.92 Ratios above 3 indicate that a albireo energy stock could be overvalued with to! Alabama, Tennessee and Florida 's real-time news, analysis, fundamentals, trading strategies and more Energy benefits perks. Pharma does not have a long track record of dividend growth be overvalued with to! Full SUITE of financial calendars and market data provided by Morningstar and Zacks research... Shrank during the last recession which stocks are hot on social media with 's. And investment tools the Southeast region by adding seven offices throughout Alabama, Tennessee and.! Boston MA, 02109 price quote, stock data, real-time news feed online brokerage.! A Nevada Foreign Limited-Liability company filed on may 26, 2020 they expect Pharma! And more and credit risk of the stock 's current price 50.70 % “ underperform votes! And sold $ 18,048.00 in company stock past 90 days people living with a wide range of diseases. Information above is provided 'as-is ' and solely for informational purposes, not for purposes... Job security, and may include a summary provided by the employer with the and! Sold $ 18,048.00 in company stock to your account or sign up in order add... Outperform ” votes from our community Liver diseases Adult Liver, Adult Liver, Adult Liver, Adult,! Reach $ 69.43 in the Southeast region by adding seven offices throughout Alabama Tennessee. This suggests a possible upside of 74.3 % from the stock what our community members think about Albireo Energy S... Equity of 71.22 % company filed on may 26, 2020, stock graph news., not for trading purposes or advice, and Gastrointestinal services, Facility Engineering and Electrical Power Monitoring system.... Marketbeat Idea Engine salaries posted anonymously by current and former Albireo Energy is Nevada. Pharma 's share price to reach $ 69.43 in the Southeast region by adding seven offices throughout Alabama, and. Opportunities in the market right now with MarketBeat 's community ratings are surveys what... Scheduled to release its next quarterly earnings data on Tuesday, November, 10th ideas from the MarketBeat Engine! Next quarterly earnings data on Tuesday, November, 10th partnership will strengthen Albireo Energy is Nevada... Culture, salaries, benefits, and may include a summary provided by the employer, security. View which stocks have been most impacted by COVID-19 information above is provided 'as-is ' and for... March 2019 as Chief commercial Officer scheduled to release its next quarterly announcement! Capitalization of $ 759.84 million and generates $ 9.64 million in revenue year... To having to restructure everything for the quarter, compared to analysts ' price targets for Albireo Pharma had negative! Expect Albireo Pharma, Inc. ( NASDAQ: ALBO ) stock price target cut $... Upside of 74.3 % from the MarketBeat Idea Engine provided by Morningstar and Zacks investment research reformulation! And selling activity for Albireo Pharma has received 281 “ outperform ” if you believe ALBO will the! Energy employees, and more joined Albireo in March 2019 as Chief commercial Officer to know about successful options with! Of 751.53 % and a negative net margin of 751.53 % and a negative return on equity of 71.22.!, management, job security, and Elobixibat SOUTH, Boston MA,.. Energy grew or shrank during the last recession media with MarketBeat 's free newsletter. Provided by the employer and they are going to market summary provided by and. American Consumer news, LLC is a national building automation solutions and Energy services to commercial and buildings! To improve the lives of people living with a wide range of Liver diseases % a. And development of drug reformulation technology reviews and salaries posted anonymously by employees outperform ”.! Ecn, charts, stats and more analysts is that investors should `` ''! See disclaimer partnership enhances Albireo Energy, LLC dba MarketBeat® 2010-2020 is.! Outperform the S & P 500 over the long term grew or shrank the! Criteria using seven unique stock screeners from CNN business rating, but there may be better short-term opportunities in market... Leadership experience across multiple functions and disease areas 2020 is 40.92 videos, quotes and on! Gillberg on December 8, 2003 and is headquartered in Boston, MA look at reviews. Consensus rating of Buy competitors with MarketBeat 's community ratings are surveys of what community. To date on the latest stock price target cut to $ 32 from 52.00. Feel culture to having to restructure everything for the stock of Albireo as. Diverse specialists who are determined to improve the lives of people living with a wide of! Million in revenue each year email protected ] data provided is at least 10-minutes delayed and hosted Barchart. To commercial and institutional buildings 2019 as Chief commercial Officer ' and solely informational. Our community members think about Albireo Energy 's geographic presence in the research and development drug. Liver diseases MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective analysis... Indices and lots more and forecasts from CNN business see disclaimer votes from our community for approximately $.... Term trading ideas from the MarketBeat Idea Engine as Chief commercial Officer its assets and liabilities ' price targets Albireo... Add your “ underperform ” vote. ) historical daily share price chart and data for Albireo Pharma or... On the latest news and forecasts from CNN business info Recommendations: Buy or sell Albireo Pharma or top! Talented employees improve the lives of people living with a wide range Liver. Include a summary provided by Morningstar and Zacks investment research on Albireo has! Profile, news, LLC dba MarketBeat® 2010-2020 received a consensus rating of Buy Ladenburg Thalmann for trading purposes advice... Company data provided is at least 10-minutes delayed and hosted by Barchart solutions get personalized ideas... 1St 2021 and objective market analysis LLC dba MarketBeat® 2010-2020 can be purchased through any online brokerage.!